Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... [...]
Author | Emmy Nominated Soap Opera Star | Cancer Hair Loss Expert
Leading Hair Loss Consultant
Amy Gibson breaks new ground again, creating the Cancer HairCARE Center by Amy Gibson premiering... [...]
Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... [...]
Camp Kesem at Syracuse University is a free, week-long summer camp for children affected by a parent’s cancer. Over 3 million children live with a parent with cancer, many more have lost a parent to... [...]
The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths.
Ever since inherited mutations in BRCA genes were first linked to breast and ovarian cancer two decades ago, this information has been used as a way to help empower women. Those who have the mutations... [...]
The PARP inhibitor niraparib improves the time to cancer progression among patients with recurrent ovarian cancer when used as maintenance therapy during platinum-based chemotherapy.
Each year in the United... [...]
The orally administered liquid formulation, Syndros (dronabinol), has been approved by the United States Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting.... [...]
For many women, juggling professional success and family life presents challenges. Bringing home the skills that serve you in the workplace might just help you organize your life at home.
By Sarah Shaw,... [...]
The information contained above is general in nature and is not intended as a guide to self-medication by consumers or meant to substitute for advice provided by your own physician or other medical professional. The reader is advised to consult with a physician or other medical professional and to check product information (including packaging inserts) for changes and new information regarding dosage, precautions, and contra indication before administering any drug, herb, supplement, compound, therapy or treatment discussed herein. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained herein.